Samsung and Mass General are studying whether Galaxy Watch8 data can help doctors monitor muscle loss during GLP-1 ...
Samsung has launched a clinical study to explore how smartwatch data can mitigate muscle mass loss in adults receiving GLP-1 therapy.
Samsung Electronics and Boston-based Massachusetts General Hospital’s Diabetes Research Center are launching a clinical study to evaluate whether the Galaxy Watch8 can help adults beginning GLP-1 ...
Samsung is using the Galaxy Watch 8 to examine users of Ozempic and other GLP-1 weight-loss drugs and offer personalized ...
Adults with overweight or obesity taking the new generation of weight loss drugs semaglutide and tirzepatide tend to eat significantly less, leaving them vulnerable to nutritional deficiencies, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results